Liu Yingfang, Lou Zhiyong, Bartlam Mark, Rao Zihe
National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Sci China C Life Sci. 2009 May;52(5):450-8. doi: 10.1007/s11427-009-0060-1. Epub 2009 May 27.
The influenza virus RNA-dependent RNA polymerase is a heterotrimeric complex (PA, PB1 and PB2) with multiple enzymatic activities for catalyzing viral RNA transcription and replication. The roles of PB1 and PB2 have been clearly defined, but PA is less well understood. The critical role of the polymerase complex in the influenza virus life cycle and high sequence conservation suggest it should be a major target for therapeutic intervention. However, until very recently, functional studies and drug discovery targeting the influenza polymerase have been hampered by the lack of three-dimensional structural information. We will review the recent progress in the structure and function of the PA subunit of influenza polymerase, and discuss prospects for the development of anti-influenza therapeutics based on available structures.
流感病毒RNA依赖的RNA聚合酶是一种异源三聚体复合物(PA、PB1和PB2),具有多种酶活性,可催化病毒RNA转录和复制。PB1和PB2的作用已得到明确界定,但对PA的了解较少。聚合酶复合物在流感病毒生命周期中的关键作用以及高度的序列保守性表明,它应是治疗干预的主要靶点。然而,直到最近,针对流感病毒聚合酶的功能研究和药物研发一直因缺乏三维结构信息而受阻。我们将综述流感病毒聚合酶PA亚基结构和功能的最新进展,并基于现有结构探讨抗流感治疗药物的研发前景。